Kiora Pharmaceuticals, Inc. KPRX
1.38 USD -0.13 (-8.61%)
At closeNov 11, 2026, 5:23 AM EST
1.38 0.00 0.00%
Pre-market · Nov 11, 5:23 AM ET
1.37 Day range 1.51
1.37 52-week range 2.91
- YTD
- -29.95%
- 1 year
- -40.77%
News
benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session Gainers Glaukos (NYSE:GKOS) shares rose 30.8% to $237.26 during Thursday's regular session. The company's market cap stands at $10.7 billion. The company's, Q3 earnings came out yesterday. Teladoc…
benzinga.com Kiora Pharmaceuticals Obtains Exclusive Development And Commercialization Rights, Outside Asia, To KIO-401 From Senju Pharmaceutical For Central Retinal Artery Occlusion For $3.5M In Upfront Payment And $285M In Additional Milestones And Royalties-8K Filing Kiora Pharmaceuticals In-Licenses Late-Stage, Oral Neuroprotective Calpain Inhibitor for Central Retinal Artery Occlusion (CRAO) with Planned Expansion into NAION; Asset Completed Phase 3 Clinical…